Microglial activation by alzhelmer amyloid precursor protein and modulation by apolipoprotein E

Nature

Volumn 388, Issue 6645, 1997, Pages 878-881

  Barger, Steven W ^a,b   Harmon, Ashley D ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; NEUROTOXIN; SERUM AMYLOID P; ALPHA SAPP PROTEIN, HUMAN; ALPHA-SAPP PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CELL ACTIVATION; CELL IMMORTALIZATION; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; MICROGLIA; MOUSE; NEUROMODULATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL DEATH; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; CELL DEATH; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-1; MICROGLIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; RATS;

EID: 0030610645     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/42257     Document Type: Article

References (29)

1. Hardy, J. New insights into the genetics of Alzheimer s disease. Ann. Med. 28, 255-258 (1996).
2. Rumble, B. et al. N. Engl. J. Med. 320, 1446-1452 (1989).
3. Griffin, W. S. et al. Microglial interleukin-1α expression in human head injury: correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci. Lett. 176, 133-136 (1994).
4. Moran, P. M., Higgins, L. S., Cordell, B. & Moser, P. C. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc. Natl Acad. Sci. USA 92, 5341-5345 (1995).
5. Mrak, R. E., Sheng, J. G. & Griffin, W. S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26, 816-823 (1995).
6. Roses, A. D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 47, 387-400 (1996).
7. Corradin, S. B., Mauel, J., Donini, S. D., Quattrocchi, E. & Ricciardi-Castagnoli, P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 7, 255-262 (1993).
8. Barger, S. W. & Mattson, M. P. Induction of neuroprotective κB-dependent transcription by secreted form of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40, 116-126 (1996).
9. Furukawa, K. et al. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a c-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896 (1996).
10. Barger, S. W. & Mattson, M. P. Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J. Neurochem. 69, 60-67 (1997).
11. Breitner, J. C. et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523-530 (1995).
12. Rogers, J. et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611 (1993).
13. Griffin, W. S., Sheng, J. G., Roberts, G. W. & Mrak, R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276-281 (1995).
14. Mayeux, R. et al. Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease. Neurology 45, 555-557 (1995).
15. Nicoll, J. R., Roberts, G. W. & Graham, D. I. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1, 135-137 (1995).
16. Sheng, J. G., Boop, F. A., Mrak, R. E. & Griffin, W. S. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α immunoreactivity. J. Neurochem. 63, 1872-1879 (1994).
17. Nordstedt, C. et al. Alzheimer β/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc. Natl Acad. Sci. USA 88, 8910-8914 (1991).
18. Martin, L. J., Pardo, C. A., Cork, L. C. & Price, D. L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358-1381 (1994).
19. Loffler, K. U., Edward, D. P. & Tso, M. O. Immunoreactivity against tau, amyloid precursor protein, and β-amyloid in the human retina. Invest. Aphthal. Vis. Sci. 36, 24-31 (1995).
20. Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993).
21. Clay, M. A. Anantharamaiah, G. M., Mistry, M. J., Balasubramaniam, A. & Harmony, J. A. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry 34, 11142-11151 (1995).
22. Meda, L. et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650 (1995).
23. Yan, S. D. et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
24. Rossi, F. & Bianchini, E. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225, 474-478 (1996).
25. Palmert, M. R. et al. Soluble derivatives of the β amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology 40, 1028-1034 (1990).
26. Van Nostrand, W. E. et al. Decreased levels of soluble amyloid β-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc. Natl Acad. Sci. USA 89, 2551-2555 (1992).
27. Giulian, D. et al. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27, 119-137 (1995).
28. Oltersdorf, T. et al. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is prutease nexin-II. Nature 341, 144-147 (1989).
29. Ostrowski, J. et al. A serine/threonine kinase activity is closely associated with a 65-kDa phospho-protein specifically recognized by the KB enhancer element. J. Biol. Chem. 266, 12722-12733 (1991).